Morphocell Technologies
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
275 Armand-frappier Blvd, Laval, Quebec,...Phone Number
(514) 373-6444Website
www.morphocell.comRevenue
$9.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Morphocell Technologies
Morphocell Technologies is a Montreal-based regenerative medicine company developing stem cellderived tissue and organ replacement therapies. Its proprietary iPSC-derived platform supports a broad pipeline of tissue-engineered solutions targeting severe organ dysfunctions, with liver disease as its first focus. Founded in 2018, Morphocell combines scientific excellence, clinical expertise, and cutting-edge manufacturing to bring next-generation regenerative therapies to patients worldwide.Explore more
Morphocell Technologies Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Morphocell Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Morphocell Technologies is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Morphocell Technologies has new funding data
Morphocell Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Morphocell Technologies
Click to see if Morphocell Technologies had a recent Job posting/layoffs
Product Launch: Get notified when Morphocell Technologies launches new products
Earning: See what the market has to say on Morphocell Technologies recently announced quarterly report
Check if Morphocell Technologies has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Morphocell Technologies as Masked Content
Find 3 more new buyers
Compare Similar Companies to Morphocell Technologies
Compare insights from companies similar to Morphocell Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Morphocell Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Morphocell Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Morphocell Technologies.
Morphocell Technologies financials insights
Gather financial insights about Morphocell Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$50M
Morphocell Technologies Tech Stack
A closer look at the technologies used by Morphocell Technologies
Most Recent Scoops
Funding
Funding
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Partnership
Partnership, Research & Development, Medical Research, Pharmaceuticals
Event
Events
Morphocell Technologies News & Media
Morphocell Technologies Completes US$50 Million Series A Financing
LAVAL, QC, Dec. 1, 2025 /PRNewswire/ - Morphocell Technologies Inc., a biotechnology company pioneering next-generation tissue therapeutics for organ replacement, today announced the completion of its US$50 million Series A financing following a US$10 million add-on led by Investissement...BioSurfaces and Morphocell Technologies Announce Collaboration to Explore Therapeutic Applications of Bio-Spun™ Material
ASHLAND, Mass., March 14, 2025 /PRNewswire/ -- BioSurfaces, a leader in advanced nanofiber materials, and Morphocell Technologies, a regenerative medicine company, are pleased to announce a collaboration aimed at exploring the potential of BioSurfaces' proprietary Bio-Spun™ material for...Morphocell Technologies Appoints Dr. Paul K. Wotton to the Board of Directors
MONTREAL--(BUSINESS WIRE)-- #celltherapy--Morphocell Technologies, a pioneer in cell therapy, announces the appointment of Dr. Paul K. Wotton as an independent member of its Board of DirectorsMorphocell Technologies Announces a New Stem Cell Process That May Pave Way for Liver Cell Therapy and Drug Development
MONTREAL--(BUSINESS WIRE)-- #celltherapy--Morphocell Technologies Inc. announces the publication of an innovative method for generating high-quality liver cells from human stem cells
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Morphocell Technologies
Sign Up For FreeTo access detailed company insights
Morphocell Technologies is a Montreal-based regenerative medicine company developing stem cellderived tissue and organ replacement therapies. Its proprietary iPSC-derived platform supports a broad pipeline of tissue-engineered solutions targeting severe organ dysfunctions, with liver disease as its first focus. Founded in 2018, Morphocell combines... Read More
